Biological process (BP) |
|
|
GO:0007049~cell cycle |
32 |
1.33E-07 |
GO:0045893~positive regulation of transcription, DNA-templated |
55 |
2.23E-07 |
GO:0000122~negative regulation of transcription from RNA polymerase II promoter |
69 |
3.35E-07 |
GO:0000209~protein polyubiquitination |
28 |
4.95E-07 |
GO:0006468~protein phosphorylation |
47 |
5.05E-06 |
GO:0045944~positive regulation of transcription from RNA polymerase II promoter |
82 |
5.62E-06 |
GO:0051301~cell division |
39 |
6.26E-06 |
GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process |
23 |
7.78E-06 |
GO:0006351~transcription, DNA-templated |
139 |
1.50E-05 |
GO:0030879~mammary gland development |
8 |
4.83E-05 |
Cellular component (CC) |
|
|
GO:0005829~cytosol |
241 |
3.09E-12 |
GO:0005737~cytoplasm |
341 |
1.53E-11 |
GO:0005654~nucleoplasm |
204 |
1.61E-10 |
GO:0005634~nucleus |
337 |
9.46E-09 |
GO:0005874~microtubule |
33 |
4.18E-05 |
GO:0035098~ESC/E (Z) complex |
7 |
6.33E-05 |
GO:0048471~perinuclear region of cytoplasm |
53 |
6.82E-05 |
GO:0043231~intracellular membrane-bounded organelle |
48 |
1.32E-04 |
GO:0030496~midbody |
18 |
1.46E-04 |
GO:0005794~Golgi apparatus |
66 |
2.07E-04 |
Molecular function (MF) |
|
|
GO:0005515~protein binding |
558 |
4.40E-18 |
GO:0061630~ubiquitin protein ligase activity |
33 |
8.23E-10 |
GO:0019901~protein kinase binding |
39 |
2.81E-05 |
GO:0004842~ubiquitin-protein transferase activity |
34 |
1.07E-04 |
GO:0044822~poly (A) RNA binding |
84 |
2.09E-04 |
GO:0008270~zinc ion binding |
86 |
2.56E-04 |
GO:0016874~ligase activity |
28 |
4.63E-04 |
GO:0004672~protein kinase activity |
34 |
5.33E-04 |
GO:0008536~Ran GTPase binding |
8 |
5.52E-04 |
GO:0004674~protein serine/threonine kinase activity |
35 |
5.92E-04 |
KEGG_PATHWAY |
|
|
hsa04722: Neurotrophin signaling pathway |
22 |
1.53E-07 |
hsa04151: PI3K-Akt signaling pathway |
39 |
7.09E-07 |
hsa04068: FoxO signaling pathway |
22 |
1.04E-06 |
hsa04510: Focal adhesion |
28 |
1.18E-06 |
hsa04914: Progesterone-mediated oocyte maturation |
17 |
2.42E-06 |
hsa04910: Insulin signaling pathway |
21 |
6.52E-06 |
hsa05211: Renal cell carcinoma |
14 |
8.29E-06 |
hsa04070: Phosphatidylinositol signaling system |
17 |
1.20E-05 |